Inventor

BRADNER JAMES

US33 patents

⚠️ This page may combine multiple inventors who share the name “BRADNER JAMES”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BRADNER JAMES

DANA FARBER CANCER INST INC

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Targeted protein degradation using a mutant E3 ubiquitin ligase

Compounds and methods for treating cancer

Compounds and methods for treating cancer

Methods to induce targeted protein degradation through bifunctional molecules

Methods to induce targeted protein degradation through bifunctional molecules

Compounds and methods for treating cancer

Regulating chimeric antigen receptors

Targeted protein degradation to attenuate adoptive T-cell therapy associated adverse inflammatory responses

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of bromodomain-containing protein 9 (BRD9) by conjugation of BRD9 inhibitors with E3 ligase ligand and methods of use

Compounds and methods for treating cancer

Tunable endogenous protein degradation

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of protein kinases by conjugation of protein kinase inhibitors with E3 ligase ligand and methods of use

Degradation of tripartite motif-containing protein 24 (TRIM24) by conjugation of TRIM24 inhibitors with E3 ligase ligand and methods of use

Chromobox protein inhibitors and uses thereof

Tunable endogenous protein degradation with heterobifunctional compounds

Folate-conjugated molecules for delivery of toxic small molecule inhibitors to cancer cells and methods of use

CHILDRENS MEDICAL CT CORP

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

Calmodulin inhibitors, Chk2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

Calmodulin inhibitors, CHK2 inhibitors and RSK inhibitors for the treatment of ribosomal disorders and ribosomapathies

BRADNER JAMES

Stabilized MAML peptides and uses thereof

H LEE MOFFITT CANCER CT & RES

Bromodomain inhibitor as adjuvant in cancer immunotherapy

YOUNG RICHARD A

Method for identifying bromodomain inhibitors

FRENCH CHRISTOPHER

Treatment of cancers characterized by chromosomal rearrangement of the NUT gene